CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973]

BACKGROUND: Chagas' disease is the major cause of disability secondary to tropical diseases in young adults from Latin America, and around 20 million people are currently infected by T. cruzi. Heart failure due to Chagas cardiomyopathy is the main clinical presenation in Colombia. Heart failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Quiros, Franklin R, Morillo, Carlos A, Casas, Juan P, Cubillos, Luz A, Silva, Federico A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1538628/
https://www.ncbi.nlm.nih.gov/pubmed/16764726
http://dx.doi.org/10.1186/1745-6215-7-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1538628/
https://www.ncbi.nlm.nih.gov/pubmed/16764726
http://dx.doi.org/10.1186/1745-6215-7-21

Ejemplares similares